Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
Muthusamy Jayaraman(Alnylam Pharmaceuticals (United States)), Michael J. Hope(Acuitas Therapeutics (Canada)), Ismail M. Hafez(University of British Columbia), Xinyao Du(Acuitas Therapeutics (Canada)), Pieter R. Cullis(University of British Columbia), Ying K. Tam(Arbutus Biopharma (Canada)), David Butler(University at Albany, State University of New York), Jayaprakash K. Narayanannair(Alnylam Pharmaceuticals (United States)), Martin A. Maier(Alnylam Pharmaceuticals (United States)), Shigeo Matsuda(Alnylam Pharmaceuticals (United States)), Akin Akinc(Alnylam Pharmaceuticals (United States)), Muthiah Manoharan(Alnylam Pharmaceuticals (United States)), Kallanthottathil G. Rajeev(Alnylam Pharmaceuticals (United States)), Jianxin Chen(Tsinghua University), Steven M. Ansell(Acuitas Therapeutics (Canada)), Mark A. Tracy(Alnylam Pharmaceuticals (United States)), Laxman Eltepu(Alnylam Pharmaceuticals (United States)), Thomas D. Madden(Arbutus Biopharma (Canada)), Barbara L. Mui(Arbutus Biopharma (Canada))
Cited by 1,219
Related Papers
Liposomal drug delivery systems: From concept to clinical applications
|Advanced Drug Delivery Reviews|2012|4.7k
Drug Delivery Systems: Entering the Mainstream
|Science|2004|4.5k
Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential
|Biochimica et Biophysica Acta (BBA) - Biomembranes|1985|2.1k
Lipid polymorphism and the functional roles of lipids in biological membranes
|Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes|1979|1.8k
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k